l9n/ New Jersey

2026–2027 Session

Senate Bill 4601

Requires pharmacist or pharmacist's designee to notify consumer of substituted drug or biological product.

In the General Assembly's Health Committee since October 29, 2026.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the Senate

1 co-sponsor

Raj Mukherji

Its course

September 28 to October 29, 2026, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action5 actions on 4 days

In the SenateSep 28 to Oct 2224 days

CommerceSep 28 to Oct 5 · moved on7 days

In the General AssemblyFrom Oct 22

HealthFrom Oct 29

Votes

Yeas to nays, as the Legislature recorded them. Committee votes are set in.

Amendments

Each amendment offered, and what became of it.

  • Senate committee amendmentAdopted

    Adopted Oct 5

Text

Each version as the Legislature printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the Legislature published it is below.

In the Senate Sep 28 – Oct 22

  1. Introduced in the Senate and sent to Commerce
  2. Sent to Health, Human Services and Senior Citizens
  3. Health, Human Services and Senior Citizens recommended it as amended
  4. Read a second time
  5. Passed the Senate, 39 to 0

In the General Assembly Oct 29

  1. Arrived in the General Assembly
  2. Sent to Health
All 5 actions, as published